"Antidotes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents counteracting or neutralizing the action of POISONS.
| Descriptor ID |
D000931
|
| MeSH Number(s) |
D27.505.696.706.037 D27.720.799.037
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antidotes".
Below are MeSH descriptors whose meaning is more specific than "Antidotes".
This graph shows the total number of publications written about "Antidotes" by people in this website by year, and whether "Antidotes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antidotes" by people in Profiles.
-
Comparison of Two-Bag Versus Three-Bag N-Acetylcysteine Regimens for Pediatric Acetaminophen Toxicity. Ann Pharmacother. 2023 01; 57(1):36-43.
-
Idarucizumab for Reversal of Dabigatran in Early/Emergency Surgeries: A Case Series. J Emerg Med. 2019 Dec; 57(6):e167-e173.
-
Evaluation and Management of Acute-Onset Hemiparesis in an Adolescent With Leukemia. Pediatr Emerg Care. 2018 Mar; 34(3):e47-e50.
-
A new therapeutic approach for carbon monoxide poisoning: Antioxidants. Toxicology. 2015 Oct 02; 336:34-5.
-
Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch Toxicol. 2014 Feb; 88(2):391-401.
-
Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem Int. 2010 Oct; 57(3):198-205.
-
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer. Anticancer Drugs. 1999 Jul; 10(6):519-24.
-
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. J Clin Oncol. 1998 May; 16(5):1712-22.
-
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. J Clin Oncol. 1998 Jan; 16(1):246-54.
-
Pharmacologic and toxicologic basis of cyanide antagonism. Proc West Pharmacol Soc. 1984; 27:149-53.